Older adults with depression face a unique obstacle — dealing with both a mental illness and the challenges that come along with aging. Currently, there are no treatments on the market targeting depression in this specific group.
The Department of Psychiatry and Behavioral Sciences has received a grant to study Sinemet, which may change that. Sinemet, a brand name for the drug levodopa, has historically treated Parkinson’s disease, a brain disorder characterized by injury to dopamine-producing neurons.